Molecular Diagnostics in Point of Care Market, Global Outlook and Forecast 2022-2028

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Molecular Diagnostics in Point of Care Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Molecular Diagnostics in Point of Care Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Molecular Diagnostics in Point of Care Overall Market Size
2.1 Global Molecular Diagnostics in Point of Care Market Size: 2021 VS 2028
2.2 Global Molecular Diagnostics in Point of Care Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Molecular Diagnostics in Point of Care Players in Global Market
3.2 Top Global Molecular Diagnostics in Point of Care Companies Ranked by Revenue
3.3 Global Molecular Diagnostics in Point of Care Revenue by Companies
3.4 Top 3 and Top 5 Molecular Diagnostics in Point of Care Companies in Global Market, by Revenue in 2021
3.5 Global Companies Molecular Diagnostics in Point of Care Product Type
3.6 Tier 1, Tier 2 and Tier 3 Molecular Diagnostics in Point of Care Players in Global Market
3.6.1 List of Global Tier 1 Molecular Diagnostics in Point of Care Companies
3.6.2 List of Global Tier 2 and Tier 3 Molecular Diagnostics in Point of Care Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Molecular Diagnostics in Point of Care Market Size Markets, 2021 & 2028
4.1.2 Polymerase Chain Reaction
4.1.3 In Situ Hybridization
4.1.4 Gene Chips
4.1.5 Next Generation Sequencing
4.2 By Type - Global Molecular Diagnostics in Point of Care Revenue & Forecasts
4.2.1 By Type - Global Molecular Diagnostics in Point of Care Revenue, 2017-2022
4.2.2 By Type - Global Molecular Diagnostics in Point of Care Revenue, 2023-2028
4.2.3 By Type - Global Molecular Diagnostics in Point of Care Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Molecular Diagnostics in Point of Care Market Size, 2021 & 2028
5.1.2 Hospitals and Clinics
5.1.3 Independent Clinical Laboratories
5.2 By Application - Global Molecular Diagnostics in Point of Care Revenue & Forecasts
5.2.1 By Application - Global Molecular Diagnostics in Point of Care Revenue, 2017-2022
5.2.2 By Application - Global Molecular Diagnostics in Point of Care Revenue, 2023-2028
5.2.3 By Application - Global Molecular Diagnostics in Point of Care Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Molecular Diagnostics in Point of Care Market Size, 2021 & 2028
6.2 By Region - Global Molecular Diagnostics in Point of Care Revenue & Forecasts
6.2.1 By Region - Global Molecular Diagnostics in Point of Care Revenue, 2017-2022
6.2.2 By Region - Global Molecular Diagnostics in Point of Care Revenue, 2023-2028
6.2.3 By Region - Global Molecular Diagnostics in Point of Care Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Molecular Diagnostics in Point of Care Revenue, 2017-2028
6.3.2 US Molecular Diagnostics in Point of Care Market Size, 2017-2028
6.3.3 Canada Molecular Diagnostics in Point of Care Market Size, 2017-2028
6.3.4 Mexico Molecular Diagnostics in Point of Care Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Molecular Diagnostics in Point of Care Revenue, 2017-2028
6.4.2 Germany Molecular Diagnostics in Point of Care Market Size, 2017-2028
6.4.3 France Molecular Diagnostics in Point of Care Market Size, 2017-2028
6.4.4 U.K. Molecular Diagnostics in Point of Care Market Size, 2017-2028
6.4.5 Italy Molecular Diagnostics in Point of Care Market Size, 2017-2028
6.4.6 Russia Molecular Diagnostics in Point of Care Market Size, 2017-2028
6.4.7 Nordic Countries Molecular Diagnostics in Point of Care Market Size, 2017-2028
6.4.8 Benelux Molecular Diagnostics in Point of Care Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Molecular Diagnostics in Point of Care Revenue, 2017-2028
6.5.2 China Molecular Diagnostics in Point of Care Market Size, 2017-2028
6.5.3 Japan Molecular Diagnostics in Point of Care Market Size, 2017-2028
6.5.4 South Korea Molecular Diagnostics in Point of Care Market Size, 2017-2028
6.5.5 Southeast Asia Molecular Diagnostics in Point of Care Market Size, 2017-2028
6.5.6 India Molecular Diagnostics in Point of Care Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Molecular Diagnostics in Point of Care Revenue, 2017-2028
6.6.2 Brazil Molecular Diagnostics in Point of Care Market Size, 2017-2028
6.6.3 Argentina Molecular Diagnostics in Point of Care Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Molecular Diagnostics in Point of Care Revenue, 2017-2028
6.7.2 Turkey Molecular Diagnostics in Point of Care Market Size, 2017-2028
6.7.3 Israel Molecular Diagnostics in Point of Care Market Size, 2017-2028
6.7.4 Saudi Arabia Molecular Diagnostics in Point of Care Market Size, 2017-2028
6.7.5 UAE Molecular Diagnostics in Point of Care Market Size, 2017-2028
7 Players Profiles
7.1 Abbott
7.1.1 Abbott Corporate Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Molecular Diagnostics in Point of Care Major Product Offerings
7.1.4 Abbott Molecular Diagnostics in Point of Care Revenue in Global Market (2017-2022)
7.1.5 Abbott Key News
7.2 Accelerate Diagnostics
7.2.1 Accelerate Diagnostics Corporate Summary
7.2.2 Accelerate Diagnostics Business Overview
7.2.3 Accelerate Diagnostics Molecular Diagnostics in Point of Care Major Product Offerings
7.2.4 Accelerate Diagnostics Molecular Diagnostics in Point of Care Revenue in Global Market (2017-2022)
7.2.5 Accelerate Diagnostics Key News
7.3 Ador Diagnostics
7.3.1 Ador Diagnostics Corporate Summary
7.3.2 Ador Diagnostics Business Overview
7.3.3 Ador Diagnostics Molecular Diagnostics in Point of Care Major Product Offerings
7.3.4 Ador Diagnostics Molecular Diagnostics in Point of Care Revenue in Global Market (2017-2022)
7.3.5 Ador Diagnostics Key News
7.4 Beckman Coulter
7.4.1 Beckman Coulter Corporate Summary
7.4.2 Beckman Coulter Business Overview
7.4.3 Beckman Coulter Molecular Diagnostics in Point of Care Major Product Offerings
7.4.4 Beckman Coulter Molecular Diagnostics in Point of Care Revenue in Global Market (2017-2022)
7.4.5 Beckman Coulter Key News
7.5 Becton, Dickinson and Company
7.5.1 Becton, Dickinson and Company Corporate Summary
7.5.2 Becton, Dickinson and Company Business Overview
7.5.3 Becton, Dickinson and Company Molecular Diagnostics in Point of Care Major Product Offerings
7.5.4 Becton, Dickinson and Company Molecular Diagnostics in Point of Care Revenue in Global Market (2017-2022)
7.5.5 Becton, Dickinson and Company Key News
7.6 Binx Health
7.6.1 Binx Health Corporate Summary
7.6.2 Binx Health Business Overview
7.6.3 Binx Health Molecular Diagnostics in Point of Care Major Product Offerings
7.6.4 Binx Health Molecular Diagnostics in Point of Care Revenue in Global Market (2017-2022)
7.6.5 Binx Health Key News
7.7 Biocartis
7.7.1 Biocartis Corporate Summary
7.7.2 Biocartis Business Overview
7.7.3 Biocartis Molecular Diagnostics in Point of Care Major Product Offerings
7.7.4 Biocartis Molecular Diagnostics in Point of Care Revenue in Global Market (2017-2022)
7.7.5 Biocartis Key News
7.8 bioM